Biotech stocks are surging. How investors can play the new drug innovation boom
Source:
cnbc
October 24, 2026 · 11:56
From the publisher
Biotech stocks are rallying as clinical wins, M&A and new drug technologies revive the sector. Here are the ETFs and stocks analysts favor.
About the source
CNBC
The Consumer News and Business Channel (CNBC) is an American business news channel owned by Versant. The network broadcasts live business news and analysis programming during the morning, daytime business day, and early-evening hours, with the remaining hours filled by business-related documentaries and reality television programming, as well as occasional sports presentations from USA Sports. CNBC operates an accompanying financial news website, CNBC.com, which includes news articles, video and…
Wikidata Q1023912
Wikidata ↗
The original article opens on the publisher's website.
More from General
View topic →Democrats, voting-rights groups challenge Trump's bid to block Alaska Senate certification
cnbc
Oct 24, 2026 · 12:57
‘Synthetic twin’: Why Socceroo Cristian Volpato is the latest footballer to license his AI clone
guardianTech
Oct 24, 2026 · 12:00
The AI graveyard: a running list of projects and startups that didn’t make it
techcrunch
Oct 24, 2026 · 12:00
Ukraine says Starlink is back to normal after disruptions
nprNews
Oct 24, 2026 · 10:54
Six Flags to Add Seatbelts on Roller Coasters After Rider’s Death
nytimes
Oct 24, 2026 · 10:06